Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Aortic Valve Stenosis

• Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure
• EMPagliflozin After Aortic Valve Replacement
• Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).
• PENG Block forTranscatheter Aortic Valve Implantation
• Effects of Pioglitazone in Calcific Aortic Valve Disease
• Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Minimally Invasive AVR
• Folic Acid Supplementation in Calcific Aortic Valve Disease
• Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
• Impact of Beta Blockers on TAVI (BETA-TAVI)
• Angiotensin Receptor-Neprilysin Inhibitor After Transcatheter Aortic Valve Implantation
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
• Evaluation of Intraoperative Dexmedetomidine Use in Patients Undergoing Surgical Aortic Valve Replacement
• Aspirin vs Clopidogrel After TAVR
• Single or Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation
• Oxford - Fibrates in Aortic Stenosis
• Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study
• Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention
• Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden
• Novel Echocardiographic and Invasive Haemodynamic Measurements in the Assessment of Patients Low Flow Low Gradient Aortic Stenosis Undergoing TAVI
• Colchicine and Inflammation in Aortic Stenosis
• A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
• AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
• Effect of PCSK9 InhibitorS On Calcific Aortic Valve DiseasE
• Angiotensin Receptor Blockers in Aortic Stenosis
• Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
• Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
• IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI
• Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
• Dapagliflozin After Transcatheter Aortic Valve Implantation
• The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
• Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
• Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation
• Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation
• Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis
• Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
• PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
• Pressure Assessment to Improve Outcomes After TAVR: a Registry
• Analgesia in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI)
• Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
• Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
• Imaging Histone Deacetylase in the Heart
• Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
• Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis
• Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
• Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
• Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
• A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI
• Rivaroxaban or Aspirin for Biological Aortic Prosthesis
• Protamine Sulfate During Transcatheter Aortic Valve Implantation
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
• Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
• Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement
• Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
• Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
• Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)
• A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification
• Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.
• Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement
• Platelet Reactivity After TAVI: A Multicenter Pilot Study
• Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
• Early Aortic Valve Lipoprotein(a) Lowering Trial
• Myocardial Efficiency of the Left Ventricle in Asymptomatic Patients With Aortic Valve Stenosis - a Prognostic Marker and a Target for Intervention?
• Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
• Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis
• Desflurane-induced Myocardial Protection
• Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
• The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI
• Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan
• Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
• Effect of Steroids on Cerebral Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement
• HaemoDYNAMICs in Primary and Secondary Hypertension
• Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
• A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)
• Effect of Bisoprolol on Progression of Aortic Stenosis
• The Effect of Losartan in Bicuspid Aortic Valve Patients
• Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study
• Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study
• Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
• Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
• Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair
• Transfemoral & Transapical Placement of Aortic Balloon Expandable Transcatheter Valves Trial (JAPAN)
• Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis
• Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease
• Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis
• Effects of Rosuvastatin on Aortic Stenosis Progression
• The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery
• The Potential of Candesartan to Retard the Progression of Aortic Stenosis
• Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis
• The Effect of Lipitor on Aortic Stenosis
• Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.
• Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
• Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis
• Statin Therapy in Asymptomatic Aortic Stenosis
• Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis
• An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)